Neuroreport · 2001 · 62 citations · 20 references
Life SciencesNeurobiologyNeuroscienceApoptosisMolecular NeuroscienceNeuropharmacologyAlzheimer DiseaseApoptosis In NeurodegenerationNeurodegenerative DiseasesNeurodegenerative DisordersNeuronal Cell DeathNeuroprotectionAlzheimer Disease NeuroprotectionAmyloid ToxicityAmyloid-associated NeurotoxicityAmyloid-beta Induced ApoptosisAmyloid-beta-induced NeurotoxicityCytochrome C Release BlockadeMitochondrial Apoptotic SignalingNeural Cell Death
Accumulating studies have shown that estrogen replacement therapy reduces the risk of Alzheimer's disease. In this study, we clarified that 17beta-estradiol (E2) significantly rescues PC12 neuronal cells from amyloid beta protein (Abeta)-induced cell death. We found that the amino acid residues of 25 to 35 (Abeta25-35) were more cytotoxic than the full length protein (Abeta1-40) and these residues induced DNA fragmentation typical for apopto- sis. In addition, E2 was confirmed to inhibit calcium influx and cytochrome c release induced by Abeta25-35. Since these sequential events cause apoptosis, the protective effect of E2 may be exerted not by the direct interaction with Abeta, but by the blockade of the mitochondrial apoptotic pathway induced by Abeta.
20
Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
Xuesong Liu, Caryn Naekyung Kim, Jie Yang et al. · Cell · 1996 · 5.2K citations · Full text
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
David M. Hockenbery, Gabriel Núñez, Curt Milliman et al. · Nature · 1990 · 3.8K citations